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ABSTRACT
While narcotic analgesics are effective in treating post-surgical pain, these commonly
prescribed medications have been shown to carry significant risks of inappropriate use,
chronic dependence, and overdose leading to death. The epidemic of opioid use in the
USA is multifactorial and in part, is the product of excessive prescribing by surgeons
treating postoperative pain.1,2 In recent years, there has been great emphasis on limiting
postoperative narcotic prescribing in adult patients. More recently, this has extended to
limiting narcotic use in pediatric patients as well due to rising concerns of persistent use
after surgery and serious adverse events in this population including death.3
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While narcotic analgesics are effective in treating
post-surgical pain, these commonly prescribed
medications have been shown to carry significant
risks of inappropriate use, chronic dependence,
and overdose leading to death. The epidemic of
opioid use in the USA is multifactorial and in part,
is the product of excessive prescribing by surgeons
treating postoperative pain.1,2 In recent years, there
has been great emphasis on limiting postoperative
narcotic prescribing in adult patients. More recently,
this has extended to limiting narcotic use in pediatric
patients as well due to rising concerns of persistent
use after surgery and serious adverse events in this
population including death.3 CDC data demonstrated
that pediatric opioid-related deaths in the US have
increased by 268% from 1999 to 2016. Approximately
9,000 children and adolescents died in this seventeen
year timeframe from opioids. Of these deaths, 73%
were due to prescription opioids, and 7% were in
children ages 0-4 years old.4 Commonly implicated
medications have included hydrocodone, oxycodone,
morphine, tramadol, codeine and buprenorphine.
The FDA released more restrictive warnings in 2017
regarding codeine and tramadol in pediatric patients.
Codeine is contraindicated in children under twelve
years old and tramadol in children under seventeen
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years old, due to multiple cases of over-sedation,
apnea and death.5
Historically post-surgical pain in the pediatric
population was generally undertreated. This is
largely due to early misconceptions about pediatric
pain sensation capabilities. Additionally, infant and
young children’s inability to verbalize or convey pain
presence and severity have led to undertreatment.6
Currently, there is concern that narcotic pain
medication is overprescribed in the pediatric
population. This concern is supported by the adverse
effects and events associated with their use. In
one study by Chung et al, 15% of their pediatric
population cohort over one year were prescribed
and filled one or more opioid prescriptions.7 Notably,
of these 1.3 million opioid prescriptions, over 50%
were for outpatient medical and dental procedures.
They found that 1 of every 2611 opioid prescriptions
resulted in an opioid related ED visit (excluding GI
or skin effects), hospitalization, or death. The vast
majority of these adverse events, 89%, were from
narcotics directly prescribed to the child, and in
71%, the narcotic medication was taken in a manner
consistent with how the medication was originally
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prescribed.7
The adverse effects in the adult population have
been well established and include sedation,
respiratory depression, dizziness, ileus, constipation,
opioid induced hyperalgesia/pain sensitivity,
immunosuppression, and hormonal dysfunction.8,9
Evidence regarding adverse effects specific to opioid
use in the pediatric population is more limited, in
part because research involving pediatric patients
and opioids is limited by ethical issues involved in
enrolling pediatric patients for clinical trials. Major
adverse effects of opioids well known to the pediatric
population include dizziness, sedation, dose-related
respiratory and CNS depression leading to apnea
and death, constipation, and nausea and vomiting.7,10
Accidental ingestion is also an important risk
especially for children under six years old. From 20102013, 13.8% of the total ED visits for unsupervised
medication exposures in the US were due to oral
narcotic ingestions.11 Additional risks in prescribing
these medications to pediatric patients include
inappropriate use by family members or others in
the home and physical dependence and addiction.
Increased availability of these narcotics in the home
and community has been shown to contribute to
overdoses in all age groups.12
Interestingly, comparisons between pain control
using narcotic and non-narcotic medications
postoperatively have demonstrated similar efficacy
in treating pain in adults as evidenced by similar
reported pain scores.9 Given the lower risks associated
with non-narcotic pain medication use and the
similar efficacy of non-narcotics in pain control, the
use of narcotics in the pediatric population should
be limited. Narcotics should be considered a second
line treatment and avoided, if possible, especially for
outpatient surgeries.
At WVU Medicine Children’s, we implemented a new
strategy since May 2019 of treating postoperative
pain without use of any narcotics in pediatric
urology patients undergoing outpatient same
day surgery that includes open and laparoscopic/
robotic procedures. Our protocol for perioperative
pain management starts during the surgery with
adequate local anesthesia for the incisional site with
bupivacaine (Marcaine) 0.25% or caudal anesthesia.
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This is followed by post-operative scheduled Tylenol
and Motrin, alternating for the next twenty four
hours, and then as needed.
We reviewed our data for all outpatient procedures
from May 1, 2019 until March 1, 2020. Of the 330
cases treated without narcotics, we have observed
no emergency department visits and have received
only two parental complaints of poorly managed
pain. One of those two parents stated that her son’s
pain after penile surgery was inadequately managed
with non-narcotic medication, but she preferred not
to give him a narcotic one.
Overall, our experience at WVU suggests that it is
feasible to eliminate postoperative narcotic use in
children undergoing outpatient surgery. This can be
done without compromising pain control or patientfamily satisfaction. Increased community awareness
of risks associated with opioids is growing and will
likely influence the preference of postoperative
analgesia toward no narcotics. A large-scale
implementation of this practice would assist in
decreasing the morbidity and mortality associated
with the current US opioid epidemic.
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